Bruce G. Allen Investments LLC Sells 46 Shares of Humana Inc. (NYSE:HUM)

Bruce G. Allen Investments LLC decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 26.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 131 shares of the insurance provider’s stock after selling 46 shares during the period. Bruce G. Allen Investments LLC’s holdings in Humana were worth $33,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in HUM. State Street Corp increased its holdings in Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after purchasing an additional 53,272 shares in the last quarter. FMR LLC boosted its holdings in Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Pzena Investment Management LLC grew its position in Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after purchasing an additional 187,903 shares in the last quarter. Marshall Wace LLP lifted its position in shares of Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares in the last quarter. Finally, Legal & General Group Plc boosted its stake in shares of Humana by 2.1% in the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after buying an additional 24,842 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Stephens reissued an “equal weight” rating and set a $250.00 target price on shares of Humana in a research report on Wednesday, October 9th. Morgan Stanley raised their price target on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Finally, KeyCorp assumed coverage on Humana in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $302.00.

Humana Price Performance

HUM traded up $1.63 on Friday, reaching $269.76. The company had a trading volume of 1,146,763 shares, compared to its average volume of 1,146,409. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $459.76. The company has a market cap of $32.48 billion, a price-to-earnings ratio of 23.89, a P/E/G ratio of 2.12 and a beta of 0.55. The business has a 50 day simple moving average of $273.07 and a 200 day simple moving average of $311.56.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, sell-side analysts anticipate that Humana Inc. will post 16.14 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. Humana’s dividend payout ratio is 31.36%.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is currently owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.